Public attitudes towards psychiatric medication: A comparison between United States and Germany

World Psychiatry

Volumn 13, Issue 3, 2014, Pages 320-321

  Schomerus, Georg ^a,b   Matschinger, Herbert ^c,d   Baumeister, Sebastian E ^a   Mojtabai, Ramin ^e   Angermeyer, Matthias C ^f,g  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b HELIOS Hanseklinikum Stralsund   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d UNIVERSITY OF HAMBURG   (Germany)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f UNIVERSITY OF CAGLIARI   (Italy)

^g Center for Public Mental Health   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PRESCRIPTION DRUG; PSYCHOTROPIC AGENT;

ANXIETY DISORDER; CONSUMER ATTITUDE; DEPRESSION; GERMANY; HEALTH SURVEY; HUMAN; LETTER; LIFE STRESS; LIKERT SCALE; PRACTICE GUIDELINE; PSYCHOPHARMACOTHERAPY; PUBLIC OPINION; RANDOM SAMPLE; UNITED STATES;

EID: 84908089117     PISSN: 17238617     EISSN: 20515545     Source Type: Journal    
DOI: 10.1002/wps.20169     Document Type: Letter

References (10)

1. Organization for Economic Co-operation and Development. Health at a glance 2013. Paris: OECD Publishing, 2013.
2. Pescosolido BA, Martin JK, Long JS et al. "A disease like any other"? A decade of change in public reactions to schizophrenia, depression, and alcohol dependence. Am J Psychiatry 2010;167: 1321-30.
3. Jorm AF, Nakane Y, Christensen H et al. Public beliefs about treatment and outcome of mental disorders: a comparison of Australia and Japan. BMC Med 2005;3:12.
4. Angermeyer MC, Matschinger H, Schomerus G. Attitudes towards psychiatric treatment and people with mental illness: changes over two decades. Br J Psychiatry 2013;203:146-51.
5. Mintzes B. Advertising of prescription-only medicines to the public: does evidence of benefit counterbalance harm? Annu Rev Public Health 2012;33:259-77.
6. Mojtabai R. Americans' attitudes toward psychiatric medications: 1998-2006. Psychiatr Serv 2009;60:1015-23.
7. Sartorius N, Kuyken W. Translation of health status instruments. In: Orley J, Kuyken W (eds). Quality of life assessment: international perspectives. Berlin: Springer, 1994:3-18.
8. Avery RJ, Eisenberg MD, Simon KI. The impact of direct-toconsumer television and magazine advertising on antidepressant use. J Health Econ 2012;31:705-18.
9. Kravitz RL, Epstein RM, Feldman MD et al. Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial. JAMA 2005;293:1995-2002.
10. Jureidini J, Mintzes B, Raven M. Does direct-to-consumer advertising of antidepressants lead to a net social benefit? Pharmacoeconomics 2008;26:557-66.